A newly-releasedWHO scientific brief summarizes the current evidence on the impact of angiotensinconverting enzyme (ACE) inhibitors and receptor blockers on severe acute respiratory illness due to COVID-19.
New interim guidance has been released by the Inter-Agency Standing Committee on how to adapt COVID-19 prevention and response measuresfor use in low capacity and humanitarian settings.
WHO launched a checklist to support prison administrators and policy-makersfor rapid and effective response to COVID-19.
WHO Director-General Dr Tedros Adhanom Ghebreyesus, referring to the fact that crises can exacerbate existing inequalities, reiteratedthat ‘We cannot end the pandemic until we address the inequalities that are fueling it.’He also highlighted six criteria that WHO recommends countries should take into account when considering the easing of lockdown restrictions.
The WHO Regional Director for the Americas, Dr. Carissa F. Etienne, warned that reducing social distancing measures “too soon could accelerate the spread of the virus and open the door for a dramatic upsurge or for spread to adjacent areas”.